Regulatory Framework & Approval ProcessQ: What is the regulatory pathway for international biotechs to conduct clinical trials in China?A: International biotechs must submit an Investigational New...
For International Sponsors – Powered by GCP ClinPlus1. What is a CGT IIT in China?In China, CGT IITs are investigator-initiated trials typically conducted at leading hospitals. They are often used ...
China just made it easier—and more rewarding—for innovative therapies to access its vast market.On July 1, 2025, China's National Healthcare Security Administration and National Health Commissio...
We are excited to announce the official launch of a Phase 1 clinical trial of Treg cell therapy for Amyotrophic Lateral Sclerosis (ALS), sponsored by NovaBio Therapeutics, at the prestigious Tiantan H...
We are proud to announce the successful completion of our Series B financing, led by Taikun Fund, one of the largest life science investment funds in China, with participation from multiple well-known...
Client OverviewBioGene-X is a leading gene editing therapeutics company in China, driven by cutting-edge gene editing technology and dedicated to pioneering innovative treatments. The company was ...
